Anti-tumor activity of three novel derivatives of ginsenoside on colorectal cancer cells

[Display omitted] •Three derivatives of 25-hydroxyprotopanaxadiol are specific to inhibite the growth of human colorectal cancer cells.•They have lesser effect on the growth of normal primary muscle cells and spleno-lymphocytes compared with cancer cells.•They could induce apoptosis via activating t...

Full description

Saved in:
Bibliographic Details
Published inSteroids Vol. 80; pp. 24 - 29
Main Authors Xia, Xichun, Jiang, Bowen, Liu, Wei, Wang, Peng, Mou, Yanhua, Liu, Yafei, Zhao, Yuqing, Bi, Xiuli
Format Journal Article
LanguageEnglish
Published United States Elsevier Inc 01.02.2014
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:[Display omitted] •Three derivatives of 25-hydroxyprotopanaxadiol are specific to inhibite the growth of human colorectal cancer cells.•They have lesser effect on the growth of normal primary muscle cells and spleno-lymphocytes compared with cancer cells.•They could induce apoptosis via activating the components of caspase-signaling pathways in HCT116 cells. 25-Hydroxyprotopanaxadiol (25-OH-PPD) is a natural compound isolated from Panax ginseng, and its anti-tumor activity has been studied in previous publication. In the current study, we investigated the anti-tumor activity of three novel derivatives synthesized from 25-OH-PPD, namely (20R)-12β-O-(l-chloracetyl)-dammarane-3β, 20, 25-triol (xl), (20R)-3β-O-(l-alanyl)-dammarane-12β, 20, 25-triol (1c), and (20R)-3β-O-(Boc-l-arginyl)-dammarane-12β, 20, 25-triol (8b). All three compounds significantly inhibited the growths of human colorectal cancer cells, while having lesser effect on the growth of normal primary muscle cells and spleno-lymphocytes. Further mechanistic study demonstrated that these compounds could induce apoptosis by activating the components of caspase-signaling pathways in HCT116 cells, but not in spleno-lymphocytes. Taken together, the results suggested that 25-OH-PPD derivatives exerted promising anti-tumor activity that is specific to human colorectal cancer cells, and may therefore represent a potential chemotherapeutic strategy for the treatment of colorectal cancer.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0039-128X
1878-5867
DOI:10.1016/j.steroids.2013.11.018